Release Date: 24/02/22 08:31 Summary: 1H FY22 Results Presentation Price Sensitive: Yes Download Document 10.23MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%